Tens of thousands of allergy sufferers are at risk because of a shortage of the life-saving EpiPen jabs. Mylan, the Pennsylvania-based firm that manufacturers the device, has warned of global supply problems.
The company has announced it will ration EpiPens, which contain a 0.3mg dose of adrenaline, in Britain. Pharmacists have cwarned of 'life or death situations' amid fears stocks of the devices could run out.
The crucial devices are used by allergy patients during a deadly anaphylactic shock - which can kill in minutes.
Pharmacists will be limited to dishing out just two EpiPens per prescription. Patients will temporarily not be able to get the gadgets without prescription.
Supply of the EpiPen for children, which contains a halved dose of epinephrine, or adrenaline, has not been affected.
